We propose that, by acting on the cytoskeleton of CNS endothelial (tip and stalk) cells and their filopodia, and by regulating vascular endothelial metabolism, NCL controls the sprouting and filopodia extension of growing CNS blood vessels during human fetal brain development and presumably in human brain tumors. Here, NUCLEOLIN is linked to brain neoplasm.